TMCI

Treace Medical Concepts, Inc. [TMCI] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

TMCI Stock Summary

Top 10 Correlated ETFs

TMCI

Top 10 Correlated Stocks

TMCI

In the News

TMCI Financial details

Company Rating
-
Market Cap
733.65M
Income
-49.21M
Revenue
187.12M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
516
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-17.85
Forward P/E
-
PEG
25.59
P/S
4.75
P/B
6.01
P/C
-
P/FCF
-15.96
Quick Ratio
4.44
Current Ratio
5.64
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.8
EPS next Y
-
EPS next Q
-
EPS this Y
-5.81%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
52.01%
Revenue last 5Y
36.55%
Revenue Q/Q
52.64%
EPS Q/Q
-64.29%
-
-
-
-
SMA20
16.67%
SMA50
-
SMA100
16.67%
Inst Own
-
Inst Trans
-
ROA
-19%
ROE
-37%
ROC
-0.23%
Gross Margin
81%
Oper. Margin
-28%
Profit Margin
-27%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.27-27.7
52W High
-76.42%
52W Low
+27.35%
RSI
45
Rel Volume
0.25
Avg Volume
435.06K
Volume
108.16K
Perf Week
-6.22%
Perf Month
-7.72%
Perf Quarter
-8.77%
Perf Half Y
-9.68%
-
-
-
-
Beta
0.277
-
-
Volatility
0.23%, 0.31%
Prev Close
0.28%
Price
6.3676
Change
-0.51%

Something similar

Top by Market Cap
VTI
JPM
ABEA.DE
FXAIX
AMZN
Top Correlated ETFs
OBND
XHYD
HYDW
NURE
EMIF
Top Correlated Stocks
TEAM
ECOR3.SA
CBRE
MMI
BCPC
Similar Market Cap
HCI
TYRA
V3AA.L
XUCD.L
SEVIX

Company Profile

Healthcare Medical - Devices
  • Volume Average 435.06K
  • Market Capitalization 733.65M
  • Employee 516
  • CEO Mr. John T. Treace
  • Headquarters Ponte Vedra,FL,US
  • IPO Date 2021-04-23
  • Website https://www.treace.com

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.